Why the study?
Endocan is a vasculoprotective molecule and indicator of endothelial function, but CIMT and serum endocan levels had not been evaluated and compared between vitiligo patients and healthy controls.
Are serum endocan levels and carotid intima media thickness increased in male patients with vitiligo compared to healthy controls?
Are serum endocan levels and carotid intima media thickness increased in male patients with vitiligo compared to healthy controls?
Vitiligo is associated with increased carotid intima media thickness and elevated serum endocan levels, suggesting an increased risk of endothelial dysfunction and subclinical atherosclerosis.
Endothelial dysfunction markers elevated in vitiligo; hypothesis-generating and should not yet change practice.
Background: Vitiligo is an acquired pigmentary disorder of the skin characterised by patches and circumscribed depigmented macules caused by epidermal melanocyte loss. A vasculoprotective molecule, endocan is an indicator of endothelial function. Objective: We aimed to evaluate carotid intima media thickness (CIMT) and serum endocan level in vitiligo patients and to compare their levels with healthy controls. Methods: This case-control study involved sixty male vitiligo patients aged 18 years or older, in addition to twenty healthy controls of the same age. A comprehensive evaluation of each patient included general and clinical examination, the Vitiligo Extent Tensity Index (VETI) score that was used to quantify the severity of vitiligo, a laboratory analysis to determine the serum endocan level, and Doppler ultrasound imaging of the CIMT. Results: No statistically significant differences were observed between the patient and control groups with respect to the age, gender, and body mass index. Patients had a significantly higher mean CIMT than the control group. Conclusion: Serum endocan and CIMT levels were significantly higher in vitiligo patients than in the control group and were significantly correlated with the severity of the disease, according to the study.
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: